Share
HAYWARD, Calif. – June 6, 2024 — Eikon Therapeutics, Inc., a pioneering biotechnology company that leverages advanced engineering to enhance drug discovery and development, today announced that CEO and Board Chair, Roger M. Perlmutter, M.D., Ph.D., and CFO, Alfred “Freddie” Bowie, Ph.D., will provide a business update highlighting pipeline and clinical development progress in a presentation at the 45th Annual Goldman Sachs Global Healthcare Conference in Miami, Florida on Wednesday, June 12, 2024 at 11:20am EDT.
A webcast of the presentation can be found here: https://cc.webcasts.com/gold006/061024a_js/?entity=193_YDUD670
About Eikon Therapeutics
Eikon Therapeutics seeks to advance breakthrough therapeutics through the purposeful integration of engineering and science. Our proprietary discovery technologies leverage Nobel Prize-winning super-resolution microscopy, advanced engineering, and high-performance computing to visualize and measure the real-time movement of proteins in living cells, with the goal of bringing important new medicines to people suffering from grievous illness. Eikon operates from its facilities in California, New Jersey, and New York and can be found online at www.EikonTx.com or LinkedIn.